AGA NSAID advisory
This article was originally published in The Tan Sheet
Executive Summary
Healthcare providers need to carefully consider the associated risks of NSAIDs before prescribing them, a multi-disciplinary panel of experts convened by the American Gastroenterological Association Institute says. The findings of the panel "Consensus Development Conference on the Use of Nonsteroidal Anti-Inflammatory Agents, Including Cyclooxygenase-2 Enzyme Inhibitors and Aspirin," were published in the September Clinical Gastroenterology and Hepatology. The panel provided recommendations for healthcare providers, which include instituting gastroprotection methods, such as proton pump inhibitors for patients at high-risk of GI complications. The AGA panel was supported through an unrestricted educational grant from TAP Pharmaceutical Products...